The therapeutic effects of melatonin and nimodipine in rats after cerebral cortical injury

Turkish Neurosurgery

Volumn 22, Issue 6, 2012, Pages 740-746

  Ismailoglu, Ozgur ^a   Atilla, Pergin ^b   Palaoglu, Selcuk ^b   Cakar, Nur ^b   Yasar, Umit ^b   Kilinc, Kamer ^b   Kaptanoglu, Erkan ^c  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Department of Neurosurgery Cyprus   (Turkey)

Author keywords

Head trauma; Melatonin; Nimodipine; Rat

Indexed keywords

EID: 84874855269     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.6197-12.1     Document Type: Article

References (38)

1. Ak A, Ustun ME, Oün CO, Duman A, Bor MA: Effects of nimodipine on tissue lactate and malondialdehyde levels in experimental head trauma. Anaesth Intensive Care 29: 484-488, 2001
2. Amenta F, Ferrante F, Ricci A, Sabbatini M: Protective effect of nicardipine treatment on cerebrovascular microanatomical changes in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22: 331-332, 1995
3. Antunes F, Barclay LR, Ingold KU, King M, Norris JQ, Scaiano JC, Xi F: On the anti-oxidant activity of melatonin. Free Radic Biol Med 26:117-128, 1999
4. Becker DP, Gudeman SK: Emergency room management of the head injured patient. In: Narayan R. K, (eds), Textbook of Head Injury. Saunders, 1988:23-66
5. Benloucif S, Bauer GL, Dubocovich ML, Finkel SI, Zee PC: Nimodipine potentiates the light-induced suppression of melatonin. Neurosci Lett 272: 67-71, 1999
6. Chesnut RM: Definitive care phase of head injuries. In: Greenfield LJ, (eds), Surgery Scientific Principles and Practice. Lippincott-Raven Pub, 1988:2991-2998
7. Dhillon HS, Carbary T, Dose J, Dempsey RJ, Prasad MR: Activation of phosphatidylinositol bisphosphate signal transduction pathway after experimental brain injury: A lipid study. Brain Res 698:100-106, 1995
8. Di Bella L, Gualano L: Key aspects of melatonin physiology: Thirty years of research. Neuro Endocrinol Lett 27:425-432, 2006
9. Dundar K, Topal T, Ay H, Oter S, Korkmaz A: Protective effects of exogenously administered or endogenously produced melatonin on hyperbaric oxygen-induced oxidative stress in the rat brain. Clin Exp Pharmacol Physiol 32:926-930, 2005
10. Ercan M, Inci S, Kilinc K, Palaoglu S, Aypar U l: Nimodipine attenuates lipid peroxidation during the acute phase of head trauma in rats. Neurosurg Rev 24:127-130, 2001
11. Gaab MR, Höllerhage HG, Walter GF, Hocheder M, Haubitz I: Brain edema, autoregulation, and calcium antagonism. An experimental study with nimodipine. Adv Neurol 52:391-400, 1990
12. Gonca Akbulut K, Gonul B, Akbulut H: Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats. Gerontology 45:67-71, 1999
13. Gorgulu A, Palaoglu S, Ismailoglu O, Tuncel M, Surucu MT, Erbil M, Kilinc K: Effect of melatonin on cerebral edema in rats. Neurosurgery 49: 1434-1441, 2001
14. Hall ED: Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 134:79-83, 1995
15. Karbownik M, Tan DX, Reiter RJ: Melatonin reduces the oxidation of nuclear DNA and membrane lipids induced by the carcinogen delta-aminolevulinic acid. Int J Cancer 88: 7-11, 2000
16. Kaynar MY, Erdincler P, Tadayyon E, Belce A, Gumustas K, Ciplak N: Effect of nimodipine and Nacetylcysteine on lipid peroxidation after experimental spinal cord injury. Neurosurg Rev 21:260-264, 1998
17. Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K: Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev 4:CD000565, 2003
18. Levati A, Solaini C, Boselli L: Prevention and treatment of vasospasm. J Neurosurg Sci 42:27-31,1998
19. Lewén A, Matz P, Chan PH: Free radical pathways in CNS injury. J Cereb Blood Flow Metab 17: 871-890, 2000
20. Loch Macdonald R: Management of cerebral vasospasm. Neurosurg Rev 29:179-193, 2006
21. Long DM, Ikeda Y: The molecular basis of brain injury and brain edema: The role of oxygen free radicals. Neurosurgery 27:1-11, 1990
22. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K: A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 80:291-300, 1994
23. Mayer TE, Dichgans M, Straube A, Birnbaum T, Müller-Schunk S, Hamann GF, Schulte-Altedorneburg G: Continuous intraarterial nimodipine for the treatment of cerebral vasospasm. Cardiovasc Intervent Radiol 4:30, 2008
24. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636-642, 1989
25. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 55: 271-276, 1994
26. Pillai SV, Kolluri VR, Mohanty A, Chandramouli BA: Evaluation of nimodipine in the treatment of severe diffuse head injury: A double-blind placebo-controlled trial. Neurol India 51: 361-363, 2003
27. Sabbatini M, Bellagamba G, Casado A, et al: Protective effect of treatment with nicardipine on cerebrovascular tree of spontaneously hypertensive rats. Clin Exp Hypertens 23: 143-155, 2001
28. Sabbatini M, Tomassoni D, Amenta F: Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats. Mech Ageing Dev 122:795-809, 2001
29. Sarrafzadeh AS, Thomale UW, Kroppenstedt SN, Unterberg AW: Neuroprotective effect of melatonin on cortical impact injury in the rat. Acta Neurochir (Wien) 142:1293-1299, 2000
30. Scriabine A, van den Kerckhoff W: Pharmacology of nimodipine. A review. Ann N Y Acad Sci 522:698-706, 1988
31. Takayasu M, Bassett JE, Dacey RG Jr: Effects of calcium antagonists on intracerebral penetrating arterioles in rats. J Neurosurg l:69:104-109, 1988
32. Vergouwen MD, Vermeulen M, Roos YB: Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: A systematic review. Lancet Neurol 5: 1029-1032, 2006
33. Wadworth AN, McTavish D: Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging 2:262-286, 1992
34. Watson BD: Usual and unusual methods for detection of lipid peroxides as indicators of tissue injury in cerebral ischemia: What is appropriate and useful? Cell Mol Neurobiol 18:581-598, 1998
35. Westenbroek RE, Bausch SB, Lin RC, Franck JE, Noebels JL, Catterall WA: Upregulation of L-type Ca2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci 18: 2321-2334, 1998
36. Weyer GW, Nolan CP, Macdonald RL: Evidence-based cerebral vasospasm management. Neurosurg Focus 15: 21-23, 2006
37. Whitfield PC, Pickard JD: Nimodipine. Br J Hosp Med 52: 539-540, 1994
38. Yang SY, Wang ZG: Therapeutic effect of nimodipine on experimental brain injury. Chin J Traumatol 6:326-331, 2003